The largest drug maker by market value, Sun Pharmaceutical is all set to replace Satyam Computer's stocks at the Bombay Stock Exchange (BSE) from January 12. BSE has expelled Satyam Computer Services from all equity indices of the stock exchange following disclosure of biggest ever corporate fraud by Satyam promoter B Ramalinga Raju and some executives.

Sun Pharmaceutical has become second Pharma Company after Daiichi Sankyo owned Ranbaxy Laboratories to get place in the Sensex. Ranjit Kapadia, head of research- PCG Group, Prabhudas Liladhar said, "Limited floating stock of Sun and investors preference to invest in a safe stocks may push the company's shares higher in the short-run.''

The information technology sector is the mostly impacted sector owing to global financial crisis and low demand in outsourcing sector. Investors have shown interest to invest in consumer goods and pharmaceutical segment in recent times and Sun has good scope to avail the opportunity.

Bombay Stock Exchange witnessed 54 per cent decline till now from its peak level of 20,873 on January 8, 2008. The shares of Sun Pharma declined 6 per cent during the given period.